The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
That means 2020 for Emergent, 2016 for Novartis, and 2017 for Texas A&M. BARDA officials told the GAO that they expect at least one CIADM will be ready to start making pandemic flu vaccine in 2017 and ...
A testament to Emergent’s ability to deliver public health threat solutions was evident through its partnership in 2012 with the Biomedical Advanced Research and Development Authority (BARDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback